Interesting background on Dr. Recknor I thought
Post# of 148292
(Total Views: 601)
Posted On: 03/16/2021 11:34:23 PM
Interesting background on Dr. Recknor
I thought those who are not familiar with Dr. Recknor's experience with Leronlimab would enjoy learning the background story. There was an article in the Atlanta Journal Constitution on June 22, 2020 about long haulers and Covid patients. Dr. Recknor was one of the patients who were profiled in the article. I find it interesting that he became aware of Leronlimab because it was successfully used to treat him. That should make him especially appreciative of the potential of this drug. Link and excerpts below.
https://www.ajc.com/lifestyles/health/for-som...2y3ezEqcN/
Dr. Chris Recknor, a Gainesville internist who runs one of the six sites for the leronlimab clinical trial, is also a COVID-19 survivor.
He first got sick in April, starting with an intense headache. Then, he started bumping into things and saw floaters in his eyes. Those aren’t the most common coronavirus symptoms, but he knew something wasn’t right and decided to get tested to, if nothing else, rule out the infectious virus. The test was positive.
His condition worsened to the point where he thought he might have a heart attack. He ended up in ER at Northeast Georgia Medical Center three times and was twice admitted for overnight stays.
“I felt like my heart was pumping so hard, it felt like it was coming out of my ears,” he said.
His physician at the hospital obtained “compassionate use” permission from the Food and Drug Administration to prescribe leronlimab.
“The only way I can explain it is, it was like it felt like I had 1,000 cups of coffee,” said Recknor. “And then after the medicine, it was like a relaxing time on the beach. A couple days after the medicine, I was back to doing everything normal. I knew there were other people like me having crazy symptoms.”
So Recknor, who is a clinical trialist and founder of the Center for Advanced Research & Education, contacted the drug company and offered to run one of the country’s clinical trial sites. Those in the trial are post-COVID survivors looking for relief after several weeks of battling the illness.
I thought those who are not familiar with Dr. Recknor's experience with Leronlimab would enjoy learning the background story. There was an article in the Atlanta Journal Constitution on June 22, 2020 about long haulers and Covid patients. Dr. Recknor was one of the patients who were profiled in the article. I find it interesting that he became aware of Leronlimab because it was successfully used to treat him. That should make him especially appreciative of the potential of this drug. Link and excerpts below.
https://www.ajc.com/lifestyles/health/for-som...2y3ezEqcN/
Dr. Chris Recknor, a Gainesville internist who runs one of the six sites for the leronlimab clinical trial, is also a COVID-19 survivor.
He first got sick in April, starting with an intense headache. Then, he started bumping into things and saw floaters in his eyes. Those aren’t the most common coronavirus symptoms, but he knew something wasn’t right and decided to get tested to, if nothing else, rule out the infectious virus. The test was positive.
His condition worsened to the point where he thought he might have a heart attack. He ended up in ER at Northeast Georgia Medical Center three times and was twice admitted for overnight stays.
“I felt like my heart was pumping so hard, it felt like it was coming out of my ears,” he said.
His physician at the hospital obtained “compassionate use” permission from the Food and Drug Administration to prescribe leronlimab.
“The only way I can explain it is, it was like it felt like I had 1,000 cups of coffee,” said Recknor. “And then after the medicine, it was like a relaxing time on the beach. A couple days after the medicine, I was back to doing everything normal. I knew there were other people like me having crazy symptoms.”
So Recknor, who is a clinical trialist and founder of the Center for Advanced Research & Education, contacted the drug company and offered to run one of the country’s clinical trial sites. Those in the trial are post-COVID survivors looking for relief after several weeks of battling the illness.
(9)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼